The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits.
Fabio Di Domenico; Raffaella Coccia; D Allan Butterfield; Marzia Perluigi (Profiled Author: Butterfield, D Allan)
Department of Biochemical Sciences, Sapienza University of Rome, Rome, Italy.
Biochimica et biophysica acta 2011;1814(12):1785-95.
Alzheimer disease (AD), the most common dementing disorder, is a multifactorial disease with complex etiology. Among different hypotheses proposed for AD one of the most corroborated is the "oxidative stress hypothesis". Although recent studies extensively demonstrated the specific oxidative modification of selected proteins in the brain of AD patients and how their dysfunction possibly correlates with the pathology, there is still an urgent need to extend these findings to peripheral tissue. So far very few studies showed oxidative damage of proteins in peripheral tissues and current findings need to be replicated. Another limit in AD research is represented by the lack of highly specific diagnostic tools for early diagnosis. For a full screening and early diagnosis, biomarkers easily detectable in biological samples, such as blood, are needed. The search of reliable biomarkers for AD in peripheral blood is a great challenge. A few studies described a set of plasma markers that differentiated AD from controls and were shown to be useful in predicting conversion from mild cognitive impairment, which is considered a prodromal stage, to AD. We review the current state of knowledge on peripheral oxidative biomarkers for AD, including proteomics, which might be useful for early diagnosis and prognosis.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Bush, Ashley I
1 May 1994 - 31 August 2007
NATIONAL INSTITUTE ON AGING
Total Funding: $ 1,215,118
1 August 1980 - 31 July 1983
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 1,472,470
DAVIS, KENNETH L
1 April 1980 - 31 March 1994
NATIONAL INSTITUTE ON AGING
Total Funding: $ 4,180,669
D Allan Butterfield; H Fai Poon; Daret St Clair; Jeffery N Keller; William M Pierce; Jon B Klein; William R MarkesberyNeurobiology of disease 2006;22(2):223-32.
Rukhsana Sultana; Debra Boyd-Kimball; H Fai Poon; Jain Cai; William M Pierce; Jon B Klein; William R Markesbery; Xiao Zhen Zhou; Kun Ping Lu; D Allan ButterfieldNeurobiology of aging 2006;27(7):918-25.
M A Smith; L M Sayre; V M Monnier; G PerryMolecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1996;28(1-3):41-8.
Appears in this Publication
Author of this Publication